Smartphone-based Financial Incentives for Smoking Cessation

University of Vermont, Burlington, VT
Targeting 2 different conditionsSmartphone-based Financial Incentives +1 moreN/ARecruitingLed by Diann Gaalema, PhDResearch Sponsored by University of Vermont

Study Summary

This trial will test the feasibility and effectiveness of a smartphone-based financial incentives intervention to help Alaska Native pregnant women quit smoking.

Eligible Conditions
  • Smoking Cessation
  • Smoking

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
You identify yourself as an Alaska Native.
You have a smartphone that runs either Android or iOS operating system.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one month after participant's enrollment date
This trial's timeline: 3 weeks for screening, Varies for treatment, and one month after participant's enrollment date for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Late Pregnancy Quit Rate
Secondary outcome measures
12-Week Postpartum Quit Rate
24-Week Postpartum Quit Rate
4-Week Postpartum Quit Rate
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Best Practices + Incentives groupExperimental Treatment2 Interventions
Participants assigned to this condition will receive the best practices treatment plus the financial incentives intervention.
Group II: Best PracticesActive Control1 Intervention
Participants assigned to this condition will receive the best practices treatment alone.
First Studied
Drug Approval Stage
How many patients have taken this drug
Best Practices

Find a site

Who is running the clinical trial?

Mayo ClinicOTHER
3,048 Previous Clinical Trials
3,484,823 Total Patients Enrolled
University of VermontLead Sponsor
258 Previous Clinical Trials
3,741,710 Total Patients Enrolled
Alaska Native Tribal Health ConsortiumOTHER
13 Previous Clinical Trials
7,770 Total Patients Enrolled
Diann Gaalema, PhDPrincipal Investigator
University of Vermont

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can people with the qualifying condition enroll in this research project at this time?

"Yes, the information available on indicates that this trial is presently recruiting patients. The trial was first announced on December 15th, 2021 and was most recently updated on June 9th, 2022. The study needs to enroll 60 patients from a single site."

Answered by AI

Who else is applying?

What state do they live in?
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
~22 spots leftby Sep 2024